SHOULDER INNOVATIONS, INC. 8-K

What Happened

• On April 27, 2026, Shoulder Innovations, Inc. announced the full commercial launch of the InSet™ I-135RFX Humeral Stem via a press release. The company furnished the press release as Exhibit 99.1 to its Form 8-K under Item 7.01 (Regulation FD Disclosure).
• The Form 8-K was signed by Jeffrey Points, Chief Financial Officer, on behalf of the company.

Key Details

• Date of announcement: April 27, 2026.
• Product: InSet™ I-135RFX Humeral Stem — announced as fully commercially launched.
• Disclosure type: Furnished under Item 7.01 (Regulation FD); press release provided as Exhibit 99.1.
• Filing note: The disclosure and Exhibit 99.1 are furnished (not “filed”) and are not subject to Section 18 liability or automatically incorporated by reference into other SEC filings.

Why It Matters

• A full commercial launch signals the company is moving the product from development/limited release to broader market availability, which can be a potential revenue driver if uptake follows.
• The 8-K does not include sales, revenue guidance, or financial impacts; investors should look for future filings or company updates for quantified results.
• This is a material operational update for shareholders tracking product pipeline progress, commercialization milestones, and potential market expansion.